The first meeting of the Asset High Level Policy Forum was held in Bruxelles on March 12. The Forum was intended to bring together selected European policy-makers at regional, national and EU levels, key decision makers in health agencies, the pharmaceutical industry, and civil society organisations, in a unique and interactive dialogue to promote on-going reflection on EU strategic priorities about pandemics.
The debate over measles vaccine is underway in many countries and, in some cases, the discussion came to court. It happened, for instance, in Italy in 2012, when a judge recognized the right to compensation (required by Italian law) for the family of a child vaccinated in 2002 with the trivalent vaccine MPR (measles-mumps-rubella) who were later diagnosed with autism. During the debate, the consultant of the family presented the research of the English physician Andrew Wakefield.
Recognize and respect fear. This is one of the main lessons Ron Klain claims to have learned by his efforts against Ebola. Klain has recently served as the first White House Ebola Response Coordinator, also known as the Ebola Czar. From such a high position, he got a close and deep insight into the dramatic threat to global health represented by the West Africa outbreak.
The recent cases of measles outbreaks in US and Europe reignited the debate on vaccines, the science behind them and the conflict between the right to individual freedom and the state intervention. Amongst the several factors that contribute to the decrease of vaccination coverage – especially in some groups – vaccine hesitancy is one of particular interest, which should require much greater attention from public health and epidemiology, medical sociology, anthropology, and the behavioural, economic and political sciences.
According to the last news from FluNews Europe, the current wave of influenza is causing a higher level of mortality among elderly people compared to the four previous seasons. In fact, an excess of all-cause mortality among the elderly (aged ≥65 years), concomitant with increased influenza activity and the predominance of A(H3N2) viruses, has been observed in recent weeks in Belgium, France, Portugal, Spain, Switzerland and the United Kingdom (England, Scotland and Wales).
The recent terror attack in Paris has raised the fear in Europe, but the threat regards many countries all over the world. While the French drama was on, in Nigeria more than 2,000 people were killed and in the following days children were loaded with bombs and used as living weapons in the crowd. It is then clear that terrorist groups currently menacing the world have no scruples in using any kind of weapons. In this scenario, even a biological attack is an option that cannot be excluded.
USA are experiencing a peak in influenza activity, with the influenza A(H3N2) viruses being the most recurrent strain so far this season. A(H3N2) viruses are predominating also in Europe and in both cases they exhibit antigenic differences to the virus included in the 2014–2015 northern hemisphere influenza vaccine.
Experience from the past taught us a lot about managing and communicating infectious threats. Indeed, the A(H1N1) 2009 influenza pandemic revealed a breakdown in the communication between decision makers, scientific institutions and the public. The milder than expected evolution of the A(H1N1) 2009 pandemic, notably, seemed to be a proof that the declaration of an emergency “had been drive” by economic interests. Many studies show that this event caused a loss of trust in health authorities and underestimate risks related to epidemics.
